Mount Yale Investment Advisors, LLC Gilead Sciences, Inc. Transaction History

Mount Yale Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $604,569 - $690,573	10,154 Added 9.27%	119,749 $7.39 Million
Q2 2022 Aug 02, 2022	BUY	$57.72 - $65.01 $207,561 - $233,775	3,596 Added 3.39%	109,595 $6.77 Million
Q1 2022 May 03, 2022	BUY	$57.92 - $72.58 $6.14 Million - $7.69 Million	105,999 New	105,999 $6.3 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $276,001 - $360,161	-4,559 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $376,857 - $417,250	-5,287 Reduced 53.7%	4,559 $330,000
Q2 2018 Aug 22, 2018	BUY	$64.88 - $75.68 $332,964 - $388,389	5,132 Added 108.87%	9,846 $697,000
Q1 2018 Jun 25, 2018	BUY	$72.84 - $88.8 $343,367 - $418,603	4,714 New	4,714 $355,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.